Signos raises $20M for glucose monitoring system for weight management.

{
  "signal_id": "1c1aa5b4-b980-4f69-9db6-8cb30ddda2cb",
  "signal_type": "news",
  "signal_subtype": "invests_into",
  "detected_at": "2026-05-27T00:00:00+00:00",
  "company": {
    "name": "Dexcom",
    "domain": "dexcom.com"
  },
  "data": {
    "url": "https://www.mobihealthnews.com/news/signos-raises-20m-glucose-monitoring-system-weight-management",
    "title": "Signos raises $20M for glucose monitoring system for weight management.",
    "ticker": "NASDAQ:DXCM",
    "excerpt": "Signos raises $20M for glucose monitoring system for weight management.\n\nThe investment comes from Dexcom, Google Ventures and Blue Cross Blue Shield of Alabama, with availability to purchase the device through Dexcom's Stelo website.\n\nSignos, maker of an over-the-counter glucose monitoring system for weight management, announced it secured $20 million in funding and a partnership with continuous glucose monitoring company Dexcom.\n\nDexcom, GV (Google Ventures) and Blue Cross Blue Shield of Alabama participated in funding the round.\n\nThrough the partnership with Dexcom, Signos will be available for purchase through Dexcom's direct-to-consumer continuous glucose monitoring website.\n\nWHAT IT DOES\n\nSignos offers an FDA-cleared mobile app that uses an over-the-counter glucose monitor to provide insights into how behavior and lifestyle affect weight. The system can help detect low and high glucose levels.\n\nThe California-based company, launched in 2018, said glucose data from Dexcom's Stelo is processed through its AI app and gives insights into a wearer's metabolic patterns, including which foods affect their glucose levels.\n\nThe recent investment will be used to accelerate the company's growth.\n\n\"Signos has developed a system that translates glucose biosensing data into actionable insights for people focused on weight management,\" Jon Coleman, chief commercial officer at Dexcom...",
    "summary": "Dexcom, Inc. invested into Nutromics Pty $14M on Jul 1st '22.",
    "planning": false,
    "image_url": "https://www.mobihealthnews.com/sites/mhn/files/2026-05/Grocery%20shopper%20holding%20phone_Mobi_Getty-Yasser%20Chalid.jpg",
    "confidence": 0.5975,
    "published_at": "2026-05-27T00:00:00Z",
    "effective_date": "2022-07-01",
    "article_sentence": "In 2022, Dexcom Ventures invested $14 million in medtech startup Nutromics.",
    "amount_normalized": 14000000,
    "related_company_name": "Nutromics Pty",
    "related_company_domain": "nutromics.com"
  }
}

curl https://signals.autobound.ai/v1/signals/1c1aa5b4-b980-4f69-9db6-8cb30ddda2cb \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"dexcom.com","limit":20}'